Chi­na green­lights sec­ond home­grown PD-1 in 10 days as In­novent cel­e­brates its first drug OK with Eli Lil­ly

You can count on the crowd­ed pool of made-in-Chi­na check­point in­hibitors to rip­ple fast.

Chi­nese reg­u­la­tors have hand­ed an ap­proval to In­novent and its part­ners …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA